7.39
전일 마감가:
$6.78
열려 있는:
$6.94
하루 거래량:
16,069
Relative Volume:
0.33
시가총액:
$26.99M
수익:
$11.68M
순이익/손실:
$-8.85M
주가수익비율:
-3.0664
EPS:
-2.41
순현금흐름:
$-14.61M
1주 성능:
+3.50%
1개월 성능:
-1.34%
6개월 성능:
+294.13%
1년 성능:
+299.46%
Pulmatrix Inc Stock (PULM) Company Profile
명칭
Pulmatrix Inc
전화
(888) 355-4440
주소
945 CONCORD STREET, FRAMINGHAM, MA
PULM을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
PULM
Pulmatrix Inc
|
7.39 | 26.99M | 11.68M | -8.85M | -14.61M | -2.41 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
488.34 | 125.40B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
718.16 | 78.51B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
580.43 | 35.27B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
238.74 | 30.91B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beone Medicines Ltd Adr
|
245.71 | 26.37B | 3.32B | -860.46M | -1.04B | -8.32 |
Pulmatrix Inc Stock (PULM) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2018-02-09 | 개시 | H.C. Wainwright | Buy |
Pulmatrix Inc 주식(PULM)의 최신 뉴스
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TGI, PULM, CCNE, TURN on Behalf of Shareholders - The Malaysian Reserve
2025-02-25 | SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TGI, PULM, CCNE, TURN on Behalf of Shareholders | NDAQ:CCNE | Press Release - Stockhouse Publishing
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Pulmatrix, Inc. (PULM) - TradingView
PULM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Pulmatrix, Inc. Is Fair to Shareholders - Business Wire
PULM stock soars to 52-week high, touches $8.5 amid robust gains - Investing.com India
PULM stock soars to 52-week high, touches $8.5 amid robust gains By Investing.com - Investing.com South Africa
Pulmatrix revises bylaws, changes voting standards - MSN
Pulmatrix revises bylaws, changes voting standards By Investing.com - Investing.com Nigeria
(PULM) Proactive Strategies - Stock Traders Daily
Pulmatrix's Unique Inhaled Drug Candidate Has "Blockbuster" Potential, Says CFO Bill Duke - ACCESS Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PULM and ENTO on Behalf of Shareholders - accessnewswire.com
Cullgen Begins Phase 1 Dosing of its Potential First-in-Class, Oral Pan-TRK Protein Degrader for Acute and Chronic Pain - The Manila Times
SEC Form 425 filed by Pulmatrix Inc. - Quantisnow
Cullgen Begins Phase 1 Dosing of its Potential - GlobeNewswire
Aspergillosis Market Expected to rise, 2034 | Regeneron, Pulmocide, Astellas Pharma, Cipla, Pulmatrix, F2G, Cellix Bio, SCYNEXIS, TFF, Matinas BioPharma, Amplyx Pharmaceuticals, Cidara Therapeutics, I - The Globe and Mail
Pulmatrix (NASDAQ:PULM) Coverage Initiated by Analysts at StockNews.com - Defense World
Pulmatrix (NASDAQ:PULM) Earns Hold Rating from Analysts at StockNews.com - Defense World
Pulmatrix, Inc. Holds 2024 Annual Meeting of Stockholders – Final Voting Results Released - Defense World
Pulmatrix secures director positions and ratifies accounting firm - Investing.com India
Pulmatrix secures director positions and ratifies accounting firm By Investing.com - Investing.com Australia
StockNews.com Begins Coverage on Pulmatrix (NASDAQ:PULM) - Defense World
Pulmatrix (NASDAQ:PULM) Now Covered by StockNews.com - Defense World
Cullgen Entering Public Market with Pulmatrix Merger - San Diego Business Journal
Pulmatrix Announces Third Quarter 2024 Financial Results and Pro - GuruFocus.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CDE, ALVR, PULM, ENTO on Behalf of Shareholders - The Malaysian Reserve
Finansavisen - Finansavisen
Pulmatrix and Cullgen announce proposed merger - MSN
Stock Market News: Samfine Creation Holdings drops by 21.56% while Pulmatrix dropped by almost 15% during mid day trading - Business Upturn
Pulmatrix, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Pulmatrix (NASDAQ:PULM) Coverage Initiated at StockNews.com - Defense World
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates - GlobeNewswire
PULMATRIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Pulmatrix, Inc.PULM - Marketscreener.com
Pulmatrix (STU:2PU) Dividends per Share : €0.00 (TTM As of Jun. 2024) - GuruFocus.com
Pulmatrix Shares Hit 52-Week High After News of Merger Deal - MarketWatch
Zai Lab aims to raise $200M; Kronos Bio to seek ‘strategic’ options - Endpoints News
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PULM, ENTO, PIK, PFC on Behalf of Shareholders - AccessWire
U.S. Stock market top gainers: AgEagle Aerial Systems surges by 151.55% while Gaxos.ai Inc gains 47.58% in ealry trading - Business Upturn
Shareholder Alert: Ademi LLP investigates whether Pulmatrix, Inc. is obtaining a Fair Price for its Public Shareholders - The Bakersfield Californian
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AE, LBRDA, PULM, ENTO on Behalf of Shareholders - The Malaysian Reserve
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
PULM stock touches 52-week high at $2.8 amid market optimism - Investing.com India
PULM stock touches 52-week high at $2.8 amid market optimism By Investing.com - Investing.com South Africa
Pulmatrix and Cullgen to Merge - citybiz
U.S. Stock market gains: BTC Digital Ltd. gains 79.72%, Kaixin Holdings surges 57.91% during mid day trading - Business Upturn
Pulmatrix Shares Surge on Merger with Cullgen - MarketWatch
Pulmatrix To Merge With Cullgen - Contract Pharma
Cullgen and Pulmatrix set for merger, eye clinical trials By Investing.com - Investing.com South Africa
Pulmatrix and Cullgen Announce Strategic Merger Agreement - TipRanks
Cullgen and Pulmatrix set for merger, eye clinical trials - Investing.com
Cullgen to Absorb Pulmatrix, Join Nasdaq - MarketWatch
Pulmatrix announces merger agreement with Cullgen - TipRanks
Pulmatrix Inc (PULM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):